A novel strategy for physiologically based predictions of human pharmacokinetics.

Clinical Pharmacokinetics
Hannah M JonesThierry Lavé

Abstract

The major aim of this study was to develop a strategy for predicting human pharmacokinetics using physiologically based pharmacokinetic (PBPK) modelling. This was compared with allometry (of plasma concentration-time profiles using the Dedrick approach), in order to determine the best approaches and strategies for the prediction of human pharmacokinetics. PBPK and Dedrick predictions were made for 19 F. Hoffmann-La Roche compounds. A strategy for the prediction of human pharmacokinetics using PBPK modelling was proposed in this study. Predicted values (pharmacokinetic parameters, plasma concentrations) were compared with observed values obtained after intravenous and oral administration in order to assess the accuracy of the prediction methods. By following the proposed strategy for PBPK, a prediction would have been made prospectively for approximately 70% of the compounds. The prediction accuracy for these compounds in terms of the percentage of compounds with an average-fold error of <2-fold was 83%, 50%, 75%, 67%, 92% and 100% for apparent oral clearance (CL/F), apparent volume of distribution during terminal phase after oral administration (V(z)/F), terminal elimination half-life (t(1/2)), peak plasma concentration (C(max)...Continue Reading

References

Feb 1, 1991·Journal of Pharmacokinetics and Biopharmaceutics·A Bernareggi, M Rowland
Nov 1, 1989·Biopharmaceutics & Drug Disposition·R LapkaM Smíd
Nov 1, 1986·Journal of Pharmaceutical Sciences·J Mordenti
Oct 1, 1973·Journal of Pharmacokinetics and Biopharmaceutics·R L Dedrick
Aug 1, 1968·Journal of Pharmaceutical Sciences·K B Bischoff, R L Dedrick
Dec 1, 1984·Journal of Pharmacokinetics and Biopharmaceutics·Y SawadaT Iga
Dec 1, 1983·Journal of Pharmacokinetics and Biopharmaceutics·Y IgariM Hanano
Apr 1, 1982·Journal of Pharmacokinetics and Biopharmaceutics·H Boxenbaum
Jan 1, 1996·Pharmaceutical Research·S D MithaniJ B Dressman
Feb 1, 1997·The Journal of Pharmacy and Pharmacology·A HutchaleelahaM Mayersohn
Feb 1, 1997·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·P Sanwald-Ducray, J Dow
Jan 1, 1997·Pharmacology & Therapeutics·T IwatsuboY Sugiyama
Jul 1, 1997·Toxicology and Industrial Health·R P BrownR P Beliles
Jan 9, 1998·Drug Metabolism Reviews·J B Houston, D J Carlile
Jan 7, 1999·Life Sciences·I Mahmood
Sep 16, 1999·International Journal of Pharmaceutics·L X Yu, G L Amidon
Feb 9, 2000·American Journal of Physiology. Endocrinology and Metabolism·M EllmererT R Pieber
Apr 13, 2000·Journal of Clinical Pharmacology·P L Bonate, D Howard
Feb 15, 2001·Journal of Pharmaceutical Sciences·P PoulinF P Theil
Sep 29, 2001·Advanced Drug Delivery Reviews·B AgoramM B Bolger
Jan 10, 2002·Journal of Pharmaceutical Sciences·Patrick Poulin, Frank-Peter Theil
Feb 21, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ivan NestorovMalcolm Rowland
Nov 16, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Rupert P AustinRobert J Riley
Mar 21, 2003·Journal of Medicinal Chemistry·Mark C WenlockPaul D Leeson
Jul 30, 2003·Clinical Pharmacokinetics·Ivan Nestorov
Sep 13, 2003·British Journal of Clinical Pharmacology·Z E WilsonG T Tucker
Sep 23, 2003·Journal of Pharmaceutical Sciences·Olivier LuttringerThierry Lavé
Apr 22, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Hannah M JonesJ Brian Houston

❮ Previous
Next ❯

Citations

Aug 4, 2009·European Journal of Drug Metabolism and Pharmacokinetics·Kenji TabataToshio Teramura
Apr 25, 2012·Cancer Chemotherapy and Pharmacology·Binfeng XiaEugene Tan
Sep 28, 2007·Journal of Pharmacokinetics and Pharmacodynamics·Max von Kleist, Wilhelm Huisinga
Nov 26, 2009·Journal of Pharmacokinetics and Pharmacodynamics·Agnès PoirierThierry Lavé
Jul 28, 2010·Journal of Pharmacokinetics and Pharmacodynamics·Sabine Pilari, Wilhelm Huisinga
Mar 21, 2007·Pharmaceutical Research·Trudy Rodgers, Malcolm Rowland
Nov 28, 2012·Pharmaceutical Research·Claudia Suenderhauf, Neil Parrott
Apr 2, 2013·Pharmaceutical Research·Henry PertinezLeon Aarons
Mar 7, 2013·Clinical Pharmacokinetics·David Stepensky
Jan 30, 2013·Antimicrobial Agents and Chemotherapy·Michael A LyonsAnne J Lenaerts
Dec 7, 2011·Antimicrobial Agents and Chemotherapy·B ReisfeldM A Degroote
Oct 5, 2007·Annual Review of Pharmacology and Toxicology·B J Anderson, N H G Holford
Mar 13, 2009·The AAPS Journal·Hannah M JonesKenny J Watson
Dec 28, 2012·The AAPS Journal·Hannah M JonesPatrick Poulin
Dec 14, 2007·Clinical Pharmacokinetics·Vikash K SinhaClaire E Mackie
Aug 10, 2010·Clinical Pharmacokinetics·Zvi TeitelbaumAdam F Cohen
Mar 24, 2011·Future Medicinal Chemistry·Xiang-Qing Yu, Alan G E Wilson
Feb 14, 2014·Biomarkers in Medicine·Minjun ChenWeida Tong
Sep 24, 2013·Biochemical Pharmacology·Jianghong Fan, Inés A M de Lannoy
Mar 31, 2012·Future Medicinal Chemistry·Guillaume BaneyxNeil Parrott
Feb 18, 2014·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Guillaume BaneyxThierry Lavé
Jun 1, 2014·Journal of Pharmacological and Toxicological Methods·Antonello CarusoThierry Lavé
Sep 22, 2010·Annual Review of Pharmacology and Toxicology·Malcolm RowlandGeoffrey Tucker
Apr 1, 2009·Expert Opinion on Drug Metabolism & Toxicology·Kiyohiko Sugano
May 18, 2012·Expert Opinion on Drug Metabolism & Toxicology·Peng ZouDuxin Sun

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.